Amylyx gets FDA approval for Relyvrio to treat ALS in adults

By NS Healthcare Staff Writer

30 Sep 22

Relyvrio, previously known as AMX0035 in the US, is an oral, fixed-dose combination therapy intended for the treatment…

PharmaceuticalsRegulation

Sanofi, Regeneron’s Dupixent approved in US to treat prurigo nodularis

By NS Healthcare Staff Writer

29 Sep 22

The FDA approval of Dupixent is based on data from two Phase 3 PRIME and PRIME2 clinical trials,…

PharmaceuticalsRegulation

Gilead makes progress in fight against alleged counterfeit HIV drug network

By NS Healthcare Staff Writer

29 Sep 22

The firm claimed in court that it has found a network responsible for the sale of counterfeit bottles…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

ArsenalBio and Genentech team up to identify T-Cell therapies for oncology

By NS Healthcare Staff Writer

28 Sep 22

The collaboration will deploy automation, large-scale genome engineering, and advanced machine learning and artificial intelligence (AI) algorithms for…

PharmaceuticalsPartnerships and Licensing Agreements

Eisai and Biogen’s lecanemab meets primary endpoint in phase 3 AD trial

By NS Healthcare Staff Writer

28 Sep 22

The phase 3 confirmatory Clarity AD clinical trial of lecanemab also met all key secondary endpoints, while delivering…

Clinical trialsPharmaceuticals

Emergent buys exclusive rights to Chimerix’s smallpox drug Tembexa

By NS Healthcare Staff Writer

27 Sep 22

Tembexa is an oral antiviral approved by the US Food and Drug Administration (FDA) for the treatment of…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Seagen signs $700m licensing deal with LAVA for solid tumours drug candidate

By NS Healthcare Staff Writer

27 Sep 22

As per the terms of the agreement, Seagen will be granted an exclusive worldwide license for LAVA-1223 by…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

AstraZeneca gets EC approval for Ultomiris to treat gMG in adults

By NS Healthcare Staff Writer

26 Sep 22

The EC approval follows a positive opinion granted by the European Medicines Agency (EMA)’s Committee for Medicinal Products…

PharmaceuticalsRegulation

Merck prevails in patent lawsuit involving sitagliptin phosphate in US court

By NS Healthcare Staff Writer

26 Sep 22

The US District Court found both Merck patents regarding sitagliptin to be valid and infringed

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

GSK, Spero sign licence agreement for cUTI antibiotic tebipenem HBr

By NS Healthcare Staff Writer

23 Sep 22

GSK will obtain exclusive rights to develop and market Tebipenem HBr worldwide, excluding Japan and certain other Asian…

PharmaceuticalsPartnerships and Licensing Agreements